Newron Pharmaceuticals is a biopharmaceutical company based in Italy that focuses on disorders of the central nervous system and pain. It develops and brings to market small-molecule treatments, including safinamide for Parkinson's disease and ralfinamide for neuropathic pain. Its customers are mainly pharmaceutical partners and healthcare professionals who prescribe its medicines, and it works with licensing partners to commercialise its products in markets around the world.
On this site NEWRON PHARMACEUT. EO-20 appears as a stock on the XETRA Stock Exchange (Germany), code NP5, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #666 of 701 on the XETRA Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Germany yet.
TrendWeak
4/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-43.3%
From 52-week high-72.8%
MomentumWeak
11/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-31.3%
6-month return-50.2%
12-month, skipping last month-20.7%
Stability (higher is calmer)Weak
9/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)65.1%
Worst drawdown, 1 year (smaller is calmer)-77.6%
LiquidityWeak
42/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.08M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Germany when fundamentals data for this market is added. All Germany stocks.
52-wk range 6.000 – 34.650Daily closes, split-adjusted
Signals
50-day average11.335
200-day average15.807
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.662
Technical summary
Daily
Bearish
3 bullish · 2 neutral · 11 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
8.36
Bullish
EMA 10
8.68
Bullish
SMA 20
9.04
Bearish
EMA 20
9.20
Bearish
SMA 50
11.34
Bearish
EMA 50
10.69
Bearish
SMA 100
12.25
Bearish
EMA 100
12.22
Bearish
SMA 200
15.81
Bearish
EMA 200
13.61
Bearish
Oscillators (daily)
RSI (14)
43.09
Neutral
MACD (12, 26)
-0.81
Bearish
Momentum (12)
2.75
Bullish
Stochastic %K (14)
90.80
Bearish
Williams %R (14)
-9.20
Bearish
CCI (20)
-15.36
Neutral
Pivot points (classic, last session)
S3
8.29
S2
8.43
S1
8.69
Pivot
8.83
R1
9.09
R2
9.23
R3
9.49
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
